“First do no harm” and the importance of prediction in oncology

Immunotherapy of Metastatic Renal Cell Carcinoma

(2010) David F. McDermott et al.   CANCER JOURNAL

Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis

(2010) S. Mocellin et al.   JNCI-Journal of the National Cancer Institute

Meta-analysis of BCG versus mitomycin C—a deeper insight?

(2010) Andreas Böhle   Nature Reviews Urology

Identification of colorectal cancer patients with tumors carrying the TP53mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy

(2009) Ten-i Godai et al.   BMC CANCER

The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users

(2009) Monique J. Bijl et al.   BREAST CANCER RESEARCH AND TREATMENT

Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma

(2009) J.-W. Lee et al.   CLINICAL CANCER RESEARCH

Therapeutic vaccines in solid tumours: Can they be harmful?

(2009) Alexander M.M. Eggermont   EUROPEAN JOURNAL OF CANCER

Cancer mortality in long-term survivors of retinoblastoma

(2009) T. Marees et al.   EUROPEAN JOURNAL OF CANCER

Life and death by death receptors

(2009) Maria Eugenia Guicciardi et al.   FASEB JOURNAL

The Amiens Strategy: Small Phase III Trials for Clinically Relevant Progress in the War Against Cancer

(2009) John J.L. Jacobs et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Interferon in High-Risk Melanoma: End of the Era?

(2009) Filip Janku et al.   JOURNAL OF CLINICAL ONCOLOGY

CD57+ T lymphocytes and functional immune deficiency

(2009) Daniele Focosi et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein

(2009) Massimo Derenzini et al.   JOURNAL OF PATHOLOGY

Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung Cancer

(2009) Howard West et al.   Journal of Thoracic Oncology

Harnessing personalised medicine to prevent late effects

(2009) Patricia A Ganz   LANCET ONCOLOGY

pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation

(2009) Douglas A. Stewart et al.   LEUKEMIA & LYMPHOMA

Serum REG4 Level Is a Predictive Biomarker for the Response to Preoperative Chemoradiotherapy in Patients With Pancreatic Cancer

(2009) Hidetoshi Eguchi et al.   PANCREAS

Local therapy of cancer with free IL-2

(2008) Willem Den Otter et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

CYP450 pharmacogenetics for personalizing cancer therapy

(2008) Ron H.N. van Schaik   DRUG RESISTANCE UPDATES

Cytokine therapy in cancer

(2008) Kim Margolin   EXPERT OPINION ON BIOLOGICAL THERAPY

Cancer: The Road to Amiens

(2008) David J. Stewart et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiation Therapy for Prostate Cancer Increases Subsequent Risk of Bladder and Rectal Cancer: A Population Based Cohort Study

(2008) Alan M. Nieder et al.   JOURNAL OF UROLOGY

Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies

(2008) Thomas Lehrnbecher et al.   LANCET ONCOLOGY

Vaccination with in vitro grown whole tumor cells induces strong immune responses and retards tumor growth in a murine model of colorectal liver metastases

(2007) Theodora Fifis et al.   VACCINE